Book contents
- The Frith Prescribing Guidelines for People with Intellectual Disability
- Reviews
- The Frith Prescribing Guidelines for People with Intellectual Disability
- Copyright page
- Contents
- Contributors
- Foreword
- Preface
- Acknowledgements
- Chapter 1 Intellectual Disability
- Chapter 2 Prescribing Practice
- Chapter 3 Physical Health Monitoring
- Chapter 4 Mental Health Conditions in People with Intellectual Disability
- Chapter 5 Trauma in People with Intellectual Disability
- Chapter 6 Anxiety Disorders
- Chapter 7 Depression
- Chapter 8 Bipolar Disorders
- Chapter 9 Schizophrenia
- Chapter 10 Aggression and Self-Injurious Behaviour
- Chapter 11 Personality Disorders
- Chapter 12 Sexual Offences and Paraphilias
- Chapter 13 Substance Use Disorders
- Chapter 14 Attention Deficit Hyperactivity Disorder
- Chapter 15 Autism
- Chapter 16 Sleep Disorders
- Chapter 17 Epilepsy
- Chapter 18 Dementia
- Chapter 19 Eating and Drinking Difficulties
- Chapter 20 Children and Adolescents
- Chapter 21 Prescribing for Health Issues in Women with Intellectual Disability
- Chapter 22 Older People
- Index
- References
Chapter 13 - Substance Use Disorders
Published online by Cambridge University Press: 07 November 2024
Book contents
- The Frith Prescribing Guidelines for People with Intellectual Disability
- Reviews
- The Frith Prescribing Guidelines for People with Intellectual Disability
- Copyright page
- Contents
- Contributors
- Foreword
- Preface
- Acknowledgements
- Chapter 1 Intellectual Disability
- Chapter 2 Prescribing Practice
- Chapter 3 Physical Health Monitoring
- Chapter 4 Mental Health Conditions in People with Intellectual Disability
- Chapter 5 Trauma in People with Intellectual Disability
- Chapter 6 Anxiety Disorders
- Chapter 7 Depression
- Chapter 8 Bipolar Disorders
- Chapter 9 Schizophrenia
- Chapter 10 Aggression and Self-Injurious Behaviour
- Chapter 11 Personality Disorders
- Chapter 12 Sexual Offences and Paraphilias
- Chapter 13 Substance Use Disorders
- Chapter 14 Attention Deficit Hyperactivity Disorder
- Chapter 15 Autism
- Chapter 16 Sleep Disorders
- Chapter 17 Epilepsy
- Chapter 18 Dementia
- Chapter 19 Eating and Drinking Difficulties
- Chapter 20 Children and Adolescents
- Chapter 21 Prescribing for Health Issues in Women with Intellectual Disability
- Chapter 22 Older People
- Index
- References
Summary
According to the ICD-11 (World Health Organization, 2019), substance use disorders include disorders that result from a single occasion or repeated use of substances (both legal and illegal) that have psychoactive properties; all drugs that are taken in excess have in common direct activation of the brain reward system, which is involved in the reinforcement of behaviours and the production of memories. They produce such an intense activation of the reward system that normal activities may be neglected. Instead of achieving reward system activation through adaptive behaviours, drugs of abuse directly activate the reward pathways. The pharmacological mechanisms by which each class of drugs produces reward are different, but the drugs typically activate the system and produce feelings of pleasure, often referred to as a ‘high’ (American Psychiatric Association, 2013). This chapter will cover all substance use in people with intellectual disability, whether it is a problem, and alternative treatments.
- Type
- Chapter
- Information
- Publisher: Cambridge University PressPrint publication year: 2024
References
Department of Health (England) and the devolved administrations (2007). Drug Misuse and Dependence: UK Guidelines on Clinical Management. London: Department of Health (England), the Scottish Government, Welsh Assembly Government and Northern Ireland Executive. https://webarchive.nationalarchives.gov.uk/ukgwa/20130123164248mp_/http://www.nta.nhs.uk/%2fuploads%2fclinical_guidelines_2007.pdf.Google Scholar
National Institute for Clinical Excellence (2007). Drug misuse in over 16s: psychosocial interventions. National Institute for Health and Clinical Excellence. www.nice.org.uk/guidance/cg51.Google Scholar
National Institute for Health and Care Excellence (2010). Alcohol-use disorders: diagnosis and management of physical complications. Clinical guideline [CG100]. National Institute for Clinical Excellence. www.nice.org.uk/guidance/cg100.Google Scholar
National Institute for Health and Care Excellence (2011). Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence. Clinical guideline [CG115]. National Institute for Clinical Excellence. www.nice.org.uk/guidance/CG115.Google Scholar
National Institute for Health and Care Excellence (2023).Tobacco: Preventing uptake, promoting quitting and treating dependence [NG209]. National Institute for Clinical Excellence. https://www.nice.org.uk/guidance/ng209.Google Scholar
Lingford-Hughes, A., Welch, S., Peters, L., & Nutt, D. (2012). BAP updated guidelines: Evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: Recommendations from BAP. Journal of Psychopharmacology, 26(7), 899–952. https://journals.sagepub.com/doi/10.1177/0269881112444324?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed#sec–6.CrossRefGoogle ScholarPubMed
Taylor, D. M., Barnes, T. R., & Young, A. H. (2021). The Maudsley prescribing guidelines in psychiatry. John Wiley & Sons.CrossRefGoogle Scholar
References
American Psychiatric Association (2013). Substance-related and addictive disorders. In Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing, Chapter 16.Google Scholar
Baldwin, D. S., Anderson, I. M., Nutt, D. J., et al. (2014). Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology. Journal of Psychopharmacology, 28(5), 403–39.CrossRefGoogle ScholarPubMed
Bhaumik, S. & Alexander, R. (eds.) (2020). Oxford textbook of the psychiatry of intellectual disability. Oxford University Press.CrossRefGoogle Scholar
Bråthen, G., Ben‐Menachem, E., Brodtkorb, E., et al. (2005). EFNS guideline on the diagnosis and management of alcohol‐related seizures: Report of an EFNS task force. European Journal of Neurology, 12(8), 575–81.CrossRefGoogle ScholarPubMed
Cahill, K., Stevens, S., Perera, R., & Lancaster, T. (2013). Pharmacological interventions for smoking cessation: An overview and network meta‐analysis. Cochrane Database of Systematic Reviews, (5).Google Scholar
Chapman, S. L. C. & Wu, L. T. (2012). Substance abuse among individuals with intellectual disabilities. Research in Developmental Disabilities, 33(4), 1147–56.Google Scholar
Chester, V., Green, F. & Alexander, R. (2011). An audit of a smoking cessation programme for people with an intellectual disability resident in a forensic unit. Advances in Mental Health and Intellectual Disabilities, 5(1), 33–41.CrossRefGoogle Scholar
Cooper, S.A., Smiley, E., Morrison, J., Williamson, A. & Allan, L. (2007). Mental ill-health in adults with intellectual disabilities: Prevalence and associated factors. The British Journal of Psychiatry, 190(1), 27–35.CrossRefGoogle ScholarPubMed
Das-Munshi, J., Semrau, M., Barbui, C., et al. (2020). Gaps and challenges: WHO treatment recommendations for tobacco cessation and management of substance use disorders in people with severe mental illness. BMC Psychiatry, 20(1), 1–13.Google ScholarPubMed
Evins, A. E., Cather, C. & Laffer, A. (2015).Treatment of tobacco use disorders in smokers with serious mental illness: Toward clinical best practices. Harvard Review of Psychiatry, 23(2), 90.CrossRefGoogle ScholarPubMed
Forbat, L. (1999).Developing an alcohol awareness course for clients with a learning disability. British Journal of Learning Disabilities, 27(1), 16–19.CrossRefGoogle Scholar
Frielink, N., Schuengel, C., Kroon, A. & Embregts, P.J.C.M. (2015). Pretreatment for substance‐abusing people with intellectual disabilities: intervening on autonomous motivation for treatment entry. Journal of Intellectual Disability Research, 59(12), 1168–1182.CrossRefGoogle ScholarPubMed
Gates, P. J., Sabioni, P., Copeland, J., Le Foll, B. & Gowing, L. (2016). Psychosocial interventions for cannabis use disorder. Cochrane Database of Systematic Reviews, (5).Google Scholar
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B. & Lindson, N. (2020). Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews, (4).Google ScholarPubMed
Hunt, G. E., Siegfried, N., Morley, K., Brooke‐Sumner, C. & Cleary, M. (2019). Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews, (12).Google ScholarPubMed
Jahagirdar, D. & Kaunelis, D. (2017). Smoking cessation interventions for patients with severe mental illnesses: A review of clinical effectiveness and guidelines. Canadian Agency for Drugs and Technologies in Health; Aug 24. www.ncbi.nlm.nih.gov/books/NBK525600/.Google Scholar
Kerr, S., Lawrence, M., Darbyshire, C., Middleton, A. R. & Fitzsimmons, L. (2013). Tobacco and alcohol‐related interventions for people with mild/moderate intellectual disabilities: a systematic review of the literature. Journal of Intellectual Disability Research, 57(5), 393–408.CrossRefGoogle ScholarPubMed
Kiewik, M., VanderNagel, J., Engels, R. & de Jong, C. (2020). Cognitive behaviour therapy for adults with mild to borderline intellectual disabilities and substance use disorders: A feasibility study. Prevention and Intervention of Substance Use and Misuse among Persons with Intellectual Disabilities, 91.Google Scholar
Kouimtsidis, C., Bosco, A., Scior, K., et al. (2017). A feasibility randomised controlled trial of extended brief intervention for alcohol misuse in adults with mild to moderate intellectual disabilities living in the community: The EBI-LD study. Trials, 18(1), 1–12.CrossRefGoogle ScholarPubMed
McGillicuddy, N. B. & Blane, H. T. (1999). Substance use in individuals with mental retardation. Addictive Behaviors, 24(6), 869–78. https://doi.org/10.1016/S0306-4603(99)00055-6.CrossRefGoogle ScholarPubMed
Mendel, E. & Hipkins, J. (2002). Motivating learning disabled offenders with alcohol‐related problems: A pilot study. British Journal of Learning Disabilities, 30(4), 153–8.CrossRefGoogle Scholar
Nielsen, S., Gowing, L., Sabioni, P. & Le Foll, B., 2019. Pharmacotherapies for cannabis dependence. Cochrane Database of Systematic Reviews, (1).CrossRefGoogle ScholarPubMed
Poznyak, V., Reed, G. M. and Medina-Mora, M. E. (2018). Aligning the ICD-11 classification of disorders due to substance use with global service needs. Epidemiology and Psychiatric Sciences, 27(3), 212–18.CrossRefGoogle ScholarPubMed
Saunders, J. B. (2017). Substance use and addictive disorders in DSM-5 and ICD 10 and the draft ICD 11. Current Opinion in Psychiatry, 30(4), 227–37.CrossRefGoogle ScholarPubMed
Schijven, E. P., Hulsmans, D. H., VanDerNagel, J. E., et al. (2021). The effectiveness of an indicated prevention programme for substance use in individuals with mild intellectual disabilities and borderline intellectual functioning: Results of a quasi‐experimental study. Addiction, 116(2), 373–81.CrossRefGoogle ScholarPubMed
Singh, N. N., Lancioni, G. E., Winton, A. S., et al. (2011).Effects of a mindfulness-based smoking cessation program for an adult with mild intellectual disability. Research in Developmental Disabilities, 32(3), 1180–5.Google ScholarPubMed
Singh, N. N., Lancioni, G. E., Winton, A. S., et al. (2013). A mindfulness-based smoking cessation program for individuals with mild intellectual disability. Mindfulness, 4, 148–57.Google Scholar
Singh, N. N., Lancioni, G. E., Myers, R. E., et al. (2014). A randomized controlled trial of a mindfulness-based smoking cessation program for individuals with mild intellectual disability. International Journal of Mental Health and Addiction, 12, 153–68.CrossRefGoogle Scholar
Steel, A. & Ritchie, G. (2004). Psycho‐educational approach to addiction – a case study. Drugs and Alcohol Today, 4(4), 30–3.CrossRefGoogle Scholar
Steinberg, M. L., Heimlich, L. & Williams, J. M. (2009). Tobacco use among individuals with intellectual or developmental disabilities: A brief review. Intellectual and Developmental Disabilities, 47(3), 197–207.CrossRefGoogle ScholarPubMed
Swerts, C., Vandevelde, S., VanDerNagel, J. E., et al. (2017). Substance use among individuals with intellectual disabilities living independently in Flanders. Research in Developmental Disabilities, 63, 107–17.CrossRefGoogle ScholarPubMed
To, W. T., Neirynck, S., Vanderplasschen, W., Vanheule, S. & Vandevelde, S. (2014). Substance use and misuse in persons with intellectual disabilities (ID): Results of a survey in ID and addiction services in Flanders. Research in Developmental Disabilities, 35(1), 1–9.CrossRefGoogle ScholarPubMed
Tracy, J. & Hosken, R. (1997). The importance of smoking education and preventative health strategies for people with intellectual disability. Journal of Intellectual Disability Research, 41(5), 416–21.CrossRefGoogle ScholarPubMed
van Duijvenbode, N. & VanDerNagel, J. E., (2019). A systematic review of substance use (disorder) in individuals with mild to borderline intellectual disability. European Addiction Research, 25(6), 263–82.Google ScholarPubMed
Vannucchi, G., Ramella Cravaro, V. & Bertelli, M.O. (2022). Substance-related and addictive disorders in intellectual disability. In Textbook of Psychiatry for Intellectual Disability and Autism Spectrum Disorder (pp. 783–805). Springer International Publishing.CrossRefGoogle Scholar
Williams, F., Kouimtsidis, C. & Baldacchino, A. (2018). Alcohol use disorders in people with intellectual disability. BJPsych Advances, 24(4), 264–72.CrossRefGoogle Scholar
World Health Organization (2019). International statistical classification of diseases and related health problems (11th ed.).Google Scholar